Search Results
Jul 29, 2025, 10:00 ET CLG and INA Successfully Produce SAF from Biogenic Feedstock
tonnes of 5% palm oil mill effluent (POME) feedstock together with fossil-based feedstocks. The process was certified by the independent certification body Bureau Veritas d.o.o., in accordance with the International Sustainability and Carbon Certification (ISCC) standard for sustainable biofuels. CLG
More news about: Chevron Lummus Global
Jul 29, 2025, 09:22 ET Hot Chili Quarterly Report Period Ending June 30, 2025
disclosed.Date: 29 July 2025 Authorised by: By the Board (Name of body or officer authorising release – see note 4) Notes This quarterly cash flow report and the accompanying activity
More news about: Hot Chili Limited
Jul 29, 2025, 09:19 ET Deutsche Bahn určuje smerovanie pre vernostný program BahnBonus v spolupráci s technologickým partnerom Comarch
inteligentné prepojenie digitálnej excelentnosti a zamerania na používateľa. Podniky, ktoré dnes chcú získavať verných zákazníkov, musia ponúkať viac než len body: relevantnosť, postoj a skutočnú pridanú hodnotu. Presne na tom teraz pracujeme spolu s DB – s nadšením, skúsenosťami a jasnou ambíciou vytvoriť niečo
More news about: Comarch
Jul 29, 2025, 09:13 ET US Performance Academy Becomes an Official Online Academic Partner of U.S. Ski & Snowboard
Performance Academy is thrilled to announce that it has become an Official Online Academic Partner of the U.S. Ski & Snowboard, the national governing body for Olympic skiing and snowboarding.
More news about: Inspired Education Group
Jul 29, 2025, 09:00 ET Reentry Program Boosts Participant Incomes by 123%
thrive," said Sam Schaeffer, CEO of the Center for Employment Opportunities. "We're proud to contribute to a growing body of evidence showing that investing in reentry programs yields measurable and significant results—not just for individuals, but for communities and local
More news about: Center for Employment Opportunities
Jul 29, 2025, 09:00 ET Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Severe-to-Very Severe Alopecia Areata
older who weigh at least 40 kilograms. Rezpegaldesleukin is an investigational biologic therapy that targets the interleukin-2 receptor complex in the body to stimulate proliferation of inhibitory immune cells known as regulatory T cells (Tregs). Results from multiple clinical trials showed that rezpegaldesleukin
More news about: Nektar Therapeutics
Jul 29, 2025, 09:00 ET Getac and Eclypsium Partner to Deliver Secure, Rugged Solutions for Federal and Public Safety Agencies
Technology Corporation is a global leader in AI-capable rugged mobile technology and intelligent video solutions, including laptops, tablets, software, body-worn cameras, in-car video systems, digital evidence management and enterprise video analytics solutions. Getac's solutions and services are designed
More news about: Getac
Jul 29, 2025, 09:00 ET Okibo and PCI Team Up on Netflix House Project in Pennsylvania
used the Okibo robot in an identical room, and I didn't feel drained at all. I've come to really value this machine for what it is: it's saving my body. And with the company's focus on reducing ladder and scaffold use, it shows PCI cares about our long-term health and safety. I can definitely appreciate
More news about: Okibo
Jul 29, 2025, 09:00 ET NORWEGIAN CRUISE LINE ANNOUNCES NEW GREAT TIDES WATERPARK AND OTHER INDUSTRY-FIRST EXPERIENCES TO DEBUT AT GREAT STIRRUP CAY - THE GREATEST ISLAND IN THE CARIBBEAN
which features large spirals and spins that send guests in a whole other direction as they shoot down in a burst of excitement, as well as exciting body slides. To make it even easier to enjoy, select slides will include convenient conveyer belts to lift the rafts to the top of the tower, eliminating
More news about: Norwegian Cruise Line
Jul 29, 2025, 08:46 ET Vexev and U.S. Renal Care Complete Enrollment in Groundbreaking Trial Evaluating Use of Robotic Ultrasound Scanning for AV Fistula Mapping in Dialysis Clinics
in the arm, to create an access point for patients requiring dialysis. This allows blood to flow quickly and easily during treatment, which helps the body remove toxins more effectively. The VxWave Ultrasound Imaging System is a robotic tomographic ultrasound system specifically designed for upper limb
More news about: Vexev
Jul 29, 2025, 08:37 ET Adameve.Com Asks "What's The One Thing You Would Change About Your Body If You Could?"
month with more results from their annual sex survey. This month, the sex-positive company asked more than 1000 adults what's the one thing about their body they would change if they could – and their answers might come as a surprise! For females, 38% said they wanted to be thinner, followed by 22%
More news about: adameve.com
Jul 29, 2025, 08:25 ET Deutsche Bahn nastavuje budoucí směr věrnostního programu BahnBonus s technologickým partnerem Comarch
věrnosti znamená inteligentní kombinaci digitální excelence a zaměření na uživatele. Dnes musí ti, kdo chtějí věrné zákazníky, nabídnout více než jen body: relevanci, přístup a skutečnou přidanou hodnotu. Přesně na tom nyní pracujeme společně s DB – s nadšením, zkušenostmi a jasnou ambicí vytvořit něco
More news about: Comarch
Jul 29, 2025, 08:05 ET Body Vision Medical Receives Regulatory Approval for LungVision® in Brazil, Expanding Access to AI-Driven Advanced Imaging for Lung Cancer Diagnosis
https://www.supri.med.br. About Body Vision Medical Body Vision Medical believes in saving lives through the globalization of innovative medical technology. LungVision provides AI-powered real-time
More news about: Body Vision Medical
Jul 29, 2025, 08:00 ET Ramaco's Brook Mine Receives 5-Year Mining Permit
research and pilot facility related to the production of advanced carbon products and materials from coal. In connection with these activities, it holds a body of roughly 76 intellectual property patents, pending applications, exclusive licensing agreements and various trademarks. News and additional information
More news about: Ramaco Resources, Inc.
Jul 29, 2025, 08:00 ET Johnson & Johnson files with U.S. FDA to include new evidence in TREMFYA® (guselkumab) label as the only IL-23 inhibitor to demonstrate significant inhibition of joint structural damage in active psoriatic arthritis
fever, sweats, or chillsmuscle achesweight losscoughwarm, red, or painful skin or sores on your body different from your psoriasisdiarrhea or stomach painshortness of breathblood in your phlegm (mucus)burning when
More news about: Johnson & Johnson
Jul 29, 2025, 08:00 ET AbbVie Submits for U.S. FDA Approval of Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL)
provider about all of your medical conditions, including if you: have kidney or liver problems.have problems with your body salts or electrolytes, such as potassium, phosphorus, or calcium.have a history of high uric acid levels in your blood or gout.are
More news about: AbbVie
Jul 29, 2025, 07:05 ET Rooter Hero Plumbing & Air provides homeowners with tips to stay comfortable this summer without running up the energy bill
home.Regulating personal temperatures: People should stay well hydrated by drinking plenty of water, and they can also take cold showers to bring down their body temperature."Right now, there are heat waves in effect all throughout the country, including Southern California,"
More news about: Rooter Hero Plumbing & Air
Jul 29, 2025, 07:00 ET CytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business Highlights
membrane oxygenation or ECMO, and heart-lung machines), where blood is repeatedly recirculated outside the body, through our cartridges where toxic substances are removed, and then back into the body. CytoSorbents' technologies are used in a number of broad applications. Specifically, two important applications
More news about: Cytosorbents Corp
Jul 29, 2025, 06:30 ET MAUI Imaging Highlights Publication Of Baseline Imaging Analysis for Traumatic Injuries Showing Imaging Breakthrough
being held August 4-7 in Kissimmee, Florida. The authors conducted three whole-body imaging sessions with six volunteers. Sixty-five predefined views of four different anatomic regions were obtained at each session. Images were scored
More news about: MAUI
Jul 29, 2025, 06:30 ET MAUI Imaging Raises $14 Million
CT without the need for dangerous ionizing radiation (x-rays). MAUI's CET "pings" the designated part of the human body, uniquely visualizing anatomy beyond what other ultrasound systems can produce. MAUI then uses proprietary patented
More news about: MAUI
Jul 29, 2025, 06:30 ET Creyos Featured in Alzheimer's Research at AAIC 2025
cognition in a way that's both rigorous and scalable. Since then, it's been used by hundreds of colleagues around the world, contributing to a growing body of work aimed at understanding cognitive health. It's rewarding to see the role it's playing in advancing research across the field." Highlights
More news about: Creyos
Jul 29, 2025, 06:29 ET Alamar Biosciences prezentuje průkopnická data o mozkovém pTau proteinu na Mezinárodní konferenci asociace pro Alzheimerovu chorobu (AAIC)
Schott z University College London a UK DRI a dr. Cheryl Wellingtonová z University of British Columbia. Klíčové body zahrnují: Výsledky mozkového pTau: Prezentace představí data z kohorty osob narozených v
More news about: Alamar Biosciences, Inc.
Jul 29, 2025, 06:15 ET Work, Faith & Future: XL Summit 2025 Charts New Frontiers
bridges these divides. The Summit called for renewed focus on connection and collaboration across all expressions of the Church, so that ultimately, the body of Christ can be fully mobilized. Two interview panels further explored the themes of connections and generations. The first featured local pastors
More news about: At Work on Purpose
Jul 28, 2025, 22:58 ET HoneyNaps Secures Global Standards in Medical Data Security with HIPAA and ISO/IEC 27001 Certifications for its AI-Driven SOMNUM™ Cloud
its ISO/IEC 27001 certification and the successful completion of its HIPAA compliance assessment. The event was attended by the CEO of the certifying body and key company executives. During the ceremony, HoneyNaps officially announced that its information security and personal data management systems are
More news about: HoneyNaps
Jul 28, 2025, 20:16 ET "New IVIM Study Shows 21.8% Average Weight Loss Over 68 Weeks - Exceeding Outcomes Reported in Landmark GLP-1 Trials"
oversight, patients lost an average of 45.9 pounds (19.5% total body weight loss) at 52 weeks, with those extending to 68 weeks achieving an average total weight loss of 46.9 pounds (21.8%). Notably, over 99% of patients lost at least 5% of their body weight at 52 weeks, with nearly 48% losing more than 20%.
More news about: Ivim Health